The rolling application assessment that the US Food and Drug Administration is using for coronavirus therapeutics and vaccines may be among the pandemic-inspired regulatory changes that become standard practice.
FDA Commissioner Stephen Hahn said the agency’s approach to coronavirus therapeutics and vaccines, which included early engagement with sponsors and...






